IP Library Granted Patent US 7,026,354
Granted Patent B2
US 7,026,354 · App. 09/969,218 · Granted Apr 11, 2006

Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,026,354
App. No.
09/969,218
Granted
Apr 11, 2006
Kind
B2
Abstract

Compositions including an aromatic compound for inhibiting the production of exoproteins by Gram positive bacteria are disclosed. The aromatic inhibitory compounds of the present invention have the general formula: wherein R 1 is selected from the group consisting of H, —OR 5 , —R 6 C(O)H, —R 6 OH, —R 6 COOH, —OR 6 OH, —OR 6 COOH, —C(O)NH 2 , and NH 2 and salts thereof; R 5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R 6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R 7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R 8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R 2 , R 3 , and R 4 are independently selected from the group consisting of H, OH, COOH, and —C(O)R 9 ; R 9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.

Claims (5)

1. A douche formulation for inhibiting production of exoprotein from Gram positive bacteria comprising a vaginal cleansing formulation comprising a pharmaceutically acceptable carrier and from about 0.2 millimoles/liter to about 50 millimoles/liter of benzyl alcohol, wherein the benzyl alcohol is effective in inhibiting the production of exoprotein from Gram positive bacteria, and wherein the vaginal cleansing formulation is for use in a vagina.

2. The douche formulation as set forth in claim 1 , wherein the benzyl alcohol is effective in substantially inihibiting the production of Toxic Shock Syndrome Toxin-1 (TSST-1 from Staphylococcus aureus bacteria.

3. The douche formulation as set forth in claim 1 , wherein the benzyl alcohol is effective in substantially inhibiting the production of Enterotoxin B and alpha hemolysin from Staphylococcus aureus bacteria.

4. The douche formulation as set forth in claim 1 , wherein the benzyl alcohol is present in the vaginal cleansing formulation in an amount of from about 0.3 millimoles/liter to about 30 millimoles/liter.

5. The douche formulation as set forth in claim 1 , wherein the benzyl alcohol is present in the vaginal cleansing formulation in an amount of from about 1 millimoles/liter to about 15 millimoles/liter.